GlassScriptPhysician profile
Anil A Patel
NPI 1386746931
$5,127.09
in general payments reported to CMS, 2019-2025
37 companies · $868 in 2025
The $868 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $536 · 2021: $238 · 2022: $193 · 2023: $1,244 · 2024: $999 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100 · Education: $11.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,099.67 |
| Education | $11.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $634.19 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $562.34 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $531.22 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Cds - Mct/Cem Monitoring |
| Pfizer INC. | $501.91 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $447.47 | 2019-2025 | |
| Amgen INC. | $249.38 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $244.50 | 2019-2025 | Farxiga, Brilinta |
| Abbott Laboratories | $237.21 | 2019-2023 | Mitraclip |
| Medtronic Vascular, INC. | $164.52 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $159.62 | 2019-2025 | Definity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.42 | 2023-2025 | Jardiance |
| Cvrx, INC. | $112.23 | 2023-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.47 | 2019-2024 | Lifevest |
| Esperion Therapeutics, INC. | $106.53 | 2023-2025 | Nexletol |
| Medtronic, INC. | $84.63 | 2023-2025 | Linq II, Micra, Symplicity G3 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.01 | 2023-2024 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $70.79 | 2025 | Amvuttra |
| Amarin Pharma, INC. | $68.67 | 2019-2020 | |
| Irhythm Technologies, INC. | $65.01 | 2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $62.98 | 2019-2020 | |
| Philips North America LLC | $61.21 | 2023-2024 | (5044) Mcot, (Ck4) Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $51.29 | 2024-2025 | |
| Medicomp INC | $48.30 | 2023-2024 | Telepatch Cardiac Monitor |
| Biotronik INC. | $40.75 | 2019-2024 | Renamic Neo |
| Regeneron Healthcare Solutions, INC. | $38.48 | 2019-2023 | Evkeeza |
| Baxter Healthcare | $35.46 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $28.21 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $24.98 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $23.77 | 2019 | |
| Lundbeck LLC | $22.10 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $21.13 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $19.77 | 2023 | Verquvo |
| Resmed Corp | $19.12 | 2023 | |
| Edwards Lifesciences Corporation | $17.91 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $17.90 | 2019 | |
| Neuronetics, INC. | $17.52 | 2019 | |
| Indivior INC. | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.